Immunotherapy For Senescent Cell Clearance: Hallmarks, Strategies And Translational Challenges
As we age, some of our cells enter a state called “senescence.” These senescent cells stop dividing but remain metabolically active, accumulating in various tissues throughout the body. While they play beneficial roles in processes like wound healing and tumor suppression in the short term, their long-term accumulation is detrimental. These cells release a cocktail of inflammatory molecules, collectively known as the Senescence-Associated Secretory Phenotype (SASP), which can damage surrounding healthy tissue, promote chronic inflammation, and contribute to the development of numerous age-related diseases, including cancer, heart disease, and neurodegenerative disorders.
Traditionally, efforts to clear these problematic cells have focused on “senolytics,” drugs designed to selectively kill senescent cells. However, a new and exciting frontier is immunotherapy, which leverages the power of our immune system to identify and remove these cells. Our immune system naturally plays a role in clearing senescent cells, but its efficiency can decline with age.
Researchers are exploring various immunotherapeutic strategies. This includes enhancing the activity of natural killer (NK) cells, which are a type of white blood cell capable of recognizing and eliminating senescent cells. Another promising approach involves engineered T cells, such as Chimeric Antigen Receptor (CAR) T cells, which can be programmed to specifically target and destroy senescent cells based on unique markers they display on their surface. Macrophages, another type of immune cell, are also crucial in clearing apoptotic (dying) cells, including senescent ones.
By boosting or redirecting the immune system’s ability to clear senescent cells, scientists hope to develop novel therapies that can not only treat but potentially prevent a wide range of age-related conditions, ultimately promoting healthier aging. While challenges remain, such as identifying universal markers for senescent cells and understanding potential side effects, the field of senescence immunotherapy holds immense promise for the future of medicine.
Source: link to paper